Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro

Fig. 1

Immunohistochemistry staining of BRCC3 expression in nasopharyn-geal carcinoma tissues. BRCC3 expression was mainly localized within the nuclei of cancer cells. a Tumor with low BRCC3 level (200×); c Tumor with high BRCC3 level (200×); b and d demonstrated the higher magnification (400×) from the area of the box in (a) and (c) respectively. Low: low BRCC3 expression; High: high BRCC3 expression

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us